FusionVAC22_01: Fusion Transcript-based Peptide Vaccine Combined with Immune Checkpoint Inhibition
Clinical trial NCT05937295 · RECRUITING
Trial details
- NCT number
- NCT05937295
- Sponsor
- University Hospital Tuebingen
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-26
- Primary completion
- 2026-09-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.